company background image

Amrutanjan Health Care BSE:590006 Stock Report

Last Price


Market Cap







18 May, 2022


Company Financials
590006 fundamental analysis
Snowflake Score
Future Growth0/6
Past Performance3/6
Financial Health6/6

590006 Stock Overview

Amrutanjan Health Care Limited manufactures, supplies, and sells ayurvedic pain balms, non-alcoholic beverages, and sanitary napkins.

Amrutanjan Health Care Competitors













Price History & Performance

Summary of all time highs, changes and price drops for Amrutanjan Health Care
Historical stock prices
Current Share Price₹825.70
52 Week High₹1,025.55
52 Week Low₹654.65
1 Month Change-11.61%
3 Month Change2.39%
1 Year Change11.24%
3 Year Change185.31%
5 Year Change139.25%
Change since IPO7,011.97%

Recent News & Updates

Shareholder Returns

590006IN PharmaceuticalsIN Market

Return vs Industry: 590006 exceeded the Indian Pharmaceuticals industry which returned -10.4% over the past year.

Return vs Market: 590006 matched the Indian Market which returned 10.6% over the past year.

Price Volatility

Is 590006's price volatile compared to industry and market?
590006 volatility
590006 Average Weekly Movement5.3%
Pharmaceuticals Industry Average Movement7.0%
Market Average Movement7.2%
10% most volatile stocks in IN Market10.0%
10% least volatile stocks in IN Market4.8%

Stable Share Price: 590006 is less volatile than 75% of Indian stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: 590006's weekly volatility (5%) has been stable over the past year.

About the Company

1893667Sambhu Sivalenka

Amrutanjan Health Care Limited manufactures, supplies, and sells ayurvedic pain balms, non-alcoholic beverages, and sanitary napkins. The company operates through OTC Products, Beverages, and Others segments. It provides pain management products comprising pain balms and roll-ons; and back pain roll-ons and lotions, body pain gels, and joint muscle sprays, as well as diclofenac, a non-steroidal anti-inflammatory drug.

Amrutanjan Health Care Fundamentals Summary

How do Amrutanjan Health Care's earnings and revenue compare to its market cap?
590006 fundamental statistics
Market Cap₹24.08b
Earnings (TTM)₹627.12m
Revenue (TTM)₹3.93b


P/E Ratio


P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
590006 income statement (TTM)
Cost of Revenue₹1.74b
Gross Profit₹2.20b
Other Expenses₹1.57b

Last Reported Earnings

Dec 31, 2021

Next Earnings Date


Earnings per share (EPS)21.45
Gross Margin55.81%
Net Profit Margin15.94%
Debt/Equity Ratio0.4%

How did 590006 perform over the long term?

See historical performance and comparison



Current Dividend Yield


Payout Ratio


Is Amrutanjan Health Care undervalued compared to its fair value and its price relative to the market?

Valuation Score


Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • PE vs Industry

  • PE vs Market

  • PEG Ratio

  • PB vs Industry


Price to Earnings (PE) ratio

Share Price vs. Fair Value

Below Fair Value: 590006 (₹825.7) is trading above our estimate of fair value (₹319.56)

Significantly Below Fair Value: 590006 is trading above our estimate of fair value.

Price To Earnings Ratio

PE vs Industry: 590006 is poor value based on its PE Ratio (38.5x) compared to the Indian Pharmaceuticals industry average (21.4x).

PE vs Market: 590006 is poor value based on its PE Ratio (38.5x) compared to the Indian market (20.6x).

Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate 590006's PEG Ratio to determine if it is good value.

Price to Book Ratio

PB vs Industry: 590006 is overvalued based on its PB Ratio (10.1x) compared to the IN Pharmaceuticals industry average (2.6x).

Future Growth

How is Amrutanjan Health Care forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

Future Growth Score


Future Growth Score 0/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


Forecasted Pharmaceuticals & Biotech industry annual growth in earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Amrutanjan Health Care has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Past Performance

How has Amrutanjan Health Care performed over the past 5 years?

Past Performance Score


Past Performance Score 3/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: 590006 has high quality earnings.

Growing Profit Margin: 590006's current net profit margins (15.9%) are lower than last year (19.7%).

Past Earnings Growth Analysis

Earnings Trend: 590006's earnings have grown significantly by 34.2% per year over the past 5 years.

Accelerating Growth: 590006's earnings growth over the past year (6.6%) is below its 5-year average (34.2% per year).

Earnings vs Industry: 590006 earnings growth over the past year (6.6%) underperformed the Pharmaceuticals industry 12.5%.

Return on Equity

High ROE: 590006's Return on Equity (26.2%) is considered high.

Financial Health

How is Amrutanjan Health Care's financial position?

Financial Health Score


Financial Health Score 6/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: 590006's short term assets (₹2.5B) exceed its short term liabilities (₹646.3M).

Long Term Liabilities: 590006's short term assets (₹2.5B) exceed its long term liabilities (₹72.6M).

Debt to Equity History and Analysis

Debt Level: 590006 has more cash than its total debt.

Reducing Debt: 590006's debt to equity ratio has reduced from 2% to 0.4% over the past 5 years.

Debt Coverage: 590006's debt is well covered by operating cash flow (4474.5%).

Interest Coverage: 590006 earns more interest than it pays, so coverage of interest payments is not a concern.

Balance Sheet


What is Amrutanjan Health Care current dividend yield, its reliability and sustainability?

Dividend Score


Dividend Score 3/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage


Current Dividend Yield

Dividend Yield vs Market

Notable Dividend: 590006's dividend (0.56%) is higher than the bottom 25% of dividend payers in the Indian market (0.35%).

High Dividend: 590006's dividend (0.56%) is low compared to the top 25% of dividend payers in the Indian market (1.58%).

Stability and Growth of Payments

Stable Dividend: 590006's dividend payments have been volatile in the past 10 years.

Growing Dividend: 590006's dividend payments have increased over the past 10 years.

Earnings Payout to Shareholders

Earnings Coverage: With its low payout ratio (21.4%), 590006's dividend payments are well covered by earnings.

Cash Payout to Shareholders

Cash Flow Coverage: With its reasonably low cash payout ratio (36.5%), 590006's dividend payments are well covered by cash flows.

Next Steps


How experienced are the management team and are they aligned to shareholders interests?


Average board tenure


Sambhu Sivalenka (47 yo)

no data




Mr. Sambhu Prasad Sivalenka, B.Tech (USA), M.B.A. (USA) has been the Managing Director of Amrutanjan Health Care Limited and serves as its Chairman since February 13, 2012. He has been Director of Amrutan...

CEO Compensation Analysis

Compensation vs Market: Insufficient data to establish whether Sambhu's total compensation is reasonable compared to companies of similar size in the Indian market.

Compensation vs Earnings: Sambhu's compensation has been consistent with company performance over the past year.

Board Members

Experienced Board: 590006's board of directors are considered experienced (7.7 years average tenure).


Who are the major shareholders and have insiders been buying or selling?

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Company Information

Amrutanjan Health Care Limited's employee growth, exchange listings and data sources

Key Information

  • Name: Amrutanjan Health Care Limited
  • Ticker: 590006
  • Exchange: BSE
  • Founded: 1893
  • Industry: Pharmaceuticals
  • Sector: Pharmaceuticals & Biotech
  • Implied Market Cap: ₹24.076b
  • Shares outstanding: 29.23m
  • Website:

Number of Employees


  • Amrutanjan Health Care Limited
  • No.103 (Old No.42-45), Luz Church Road
  • Mylapore
  • Chennai
  • Tamil Nadu
  • 600004
  • India


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/05/18 00:00
End of Day Share Price2022/05/18 00:00
Annual Earnings2021/03/31

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.